ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.765,26
0,04%
S&P 500
5.222,68
0,16%
Dow Jones
39.512,84
0,32%
Euro vs US Dollar
1,07779
0,07%
Bitcoin
62.483,28
1,68%
Registration Strip Icon for discussion Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. Microbot Medical Inc (MBOT)

  7. Microbot Medical Inc (MBOT) News

MBOT

Microbot Medical (MBOT)

Microbot Medical Inc
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NASDAQ:MBOT
DatumZeitQuelleÜberschriftSymbolFirma
29/04/202414h30GlobeNewswire Inc.Microbot Medical Announces Positive Results from the First Phase of its Collaboration with Corewell Health™NASDAQ:MBOTMicrobot Medical Inc
15/04/202414h30GlobeNewswire Inc.Microbot Medical Shares Status Following Recent Geopolitical EventsNASDAQ:MBOTMicrobot Medical Inc
27/02/202400h41Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MBOTMicrobot Medical Inc
27/02/202400h41Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MBOTMicrobot Medical Inc
27/02/202400h41Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MBOTMicrobot Medical Inc
27/02/202400h41Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MBOTMicrobot Medical Inc
20/02/202422h35Edgar (US Regulatory)Form S-1 - General form for registration of securities under the Securities Act of 1933NASDAQ:MBOTMicrobot Medical Inc
14/02/202420h49Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:MBOTMicrobot Medical Inc
05/02/202413h30GlobeNewswire Inc.Microbot Medical Submits an IDE Application to Gain FDA Approval to Commence Its Pivotal Clinical Trial in the USNASDAQ:MBOTMicrobot Medical Inc
30/01/202422h30Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:MBOTMicrobot Medical Inc
30/01/202413h20Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:MBOTMicrobot Medical Inc
30/01/202413h20GlobeNewswire Inc.Microbot Medical Announces Settlement and Release Agreement, Effectively Resolving all Associated Legal MattersNASDAQ:MBOTMicrobot Medical Inc
26/01/202406h15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:MBOTMicrobot Medical Inc
22/01/202423h20Edgar (US Regulatory)Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]NASDAQ:MBOTMicrobot Medical Inc
18/01/202413h20Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:MBOTMicrobot Medical Inc
18/01/202413h20GlobeNewswire Inc.Microbot Medical Expands US Clinical Infrastructure in Support of the Upcoming IDE Submission to Commence its First in Human Clinical StudyNASDAQ:MBOTMicrobot Medical Inc
12/01/202422h20Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:MBOTMicrobot Medical Inc
12/01/202422h16Edgar (US Regulatory)Form S-1 - General form for registration of securities under the Securities Act of 1933NASDAQ:MBOTMicrobot Medical Inc
02/01/202423h00Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:MBOTMicrobot Medical Inc
02/01/202422h55Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:MBOTMicrobot Medical Inc
29/12/202314h00GlobeNewswire Inc.Microbot Medical Announces Exercise of Outstanding Preferred Investment Options for $2.73 Million in Gross Proceeds Priced At-the-Market Under Nasdaq RulesNASDAQ:MBOTMicrobot Medical Inc
28/12/202313h30GlobeNewswire Inc.Microbot Medical Announced Positive Results of Its GLP Pivotal Pre-Clinical Study Where All Study Objectives Were MetNASDAQ:MBOTMicrobot Medical Inc
14/12/202314h15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:MBOTMicrobot Medical Inc
14/12/202314h15GlobeNewswire Inc.Microbot Medical and Corewell Health Forge Collaboration to Establish the LIBERTY® Endovascular Robotic Surgical System for TeleroboticNASDAQ:MBOTMicrobot Medical Inc
07/12/202314h00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:MBOTMicrobot Medical Inc
07/12/202314h00GlobeNewswire Inc.Microbot Medical Announces the Successful Completion of Its GLP Pivotal Pre-Clinical Study, a Critical Milestone for Its IDE submission to Commence Human Clinical StudyNASDAQ:MBOTMicrobot Medical Inc
05/12/202306h15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:MBOTMicrobot Medical Inc
01/12/202323h15Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:MBOTMicrobot Medical Inc
30/11/202322h31Edgar (US Regulatory)Form S-3/A - Registration statement under Securities Act of 1933: [Amend]NASDAQ:MBOTMicrobot Medical Inc
21/11/202315h12GlobeNewswire Inc.Microbot Medical Appoints Seasoned Medical Expert Dr. Juan Diaz- Cartelle as its New Chief Medical Officer in Anticipation of Its Clinical, Regulatory and Commercial ActivitiesNASDAQ:MBOTMicrobot Medical Inc
 Showing the most relevant articles for your search:NASDAQ:MBOT

Kürzlich von Ihnen besucht

FX
EURGBP
Euro vs Sterling
NYSE
MCD
McDonalds
TG
MBG
MercedesBenz
TG
NOV
Novo Nordisk
CCOM
US100
US Tech 100
FX
EURUSD
Euro vs US Dollar
TG
BAYN
Bayer
NASDAQ
GOOGL
Alphabet
AMEX
SPY
SPDR S&P 500
AMEX
XLE
Energy Select Sector SPDR
COIN
BTCUSD
Bitcoin
USOTC
BASFY
BASF (QX)
TG
BAS
BASF
CCOM
US500
US 500
NASDAQ
AAPL
Apple
Delayed Upgrade Clock
ADVFN Logo

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten